Probiotic Outcomes in Enteric Microflora (POEM) Study
肠道菌群 (POEM) 研究中的益生菌结果
基本信息
- 批准号:7738964
- 负责人:
- 金额:$ 37.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2011-09-29
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAffectAgeAge-MonthsAntibioticsAsthmaAtopic DermatitisBacteriaBase CompositionBirthBloodBreast FeedingCD4 Positive T LymphocytesClinicalCollaborationsCommunitiesCommunity DevelopmentsComplexCutaneousDataData AnalysesDetectionDevelopmentDietary SupplementationDiseaseDouble-Blind MethodEczemaEnrollmentEnteralEosinophiliaExposure toFecesFluorescenceGoalsIgEImmunologic MarkersInfantIntestinesInvestigationLactobacillusLactobacillus caseiLifeMeasuresMethodsNeonatalNewborn InfantOutcomePatternPeripheral Blood Mononuclear CellPilot ProjectsPopulationPredictive ValueProbioticsRandomizedRecording of previous eventsRecurrenceResearch DesignResearch PersonnelRhinitisRibosomal RNARiskSamplingScienceSerumSiblingsStructureSupplementationTaxonTechnologyTestingTravelWheezingantigen challengeatopybasecohortdesigndouble-blind placebo controlled trialfollow-upgastrointestinalgroup interventioninfancymicrobialnovelpet animalpillplacebo controlled studypreventpublic health relevanceresponse
项目摘要
DESCRIPTION (provided by applicant): We propose the Probiotic Outcomes on Enteric Microbiotia (POEM) Study, which is a secondary data analysis of previously collected samples from the Trial of Infant Probiotic Supplementation (TIPS) Study to Prevent Markers of Asthma (HL080074). TIPS was designed to examine the effects of daily Lactobacillus casei supplementation in infants for 6 months on the development of early markers of asthma to age three; using a double-blind, placebo controlled study design with 278 infants. In the proposed POEM Study, we will apply a new and novel 16S rRNA PhyloChip microarray approach that is a culture-independent, massively parallel method for simultaneous semi-quantitative detection of bacteria. Use of a PhyloChip microarray on a sample of previously collected stool samples from the TIPS cohort (n=60) presents an opportunity for characterizing how probiotic supplementation altered the intestinal bacterial community. The overall goal of the POEM pilot study is apply a state-of-the-science technology to develop preliminary data to determine the impact of daily probiotic supplementation on the gastrointestinal bacterial community. We will (1) assess the immediate effect and (2) prolonged effect of Lactobacillus supplementation on neonatal intestinal bacterial community during and after a six-month period of supplementation and (3) correlate the effects of the bacterial community composition on the development of early markers of asthma. We hypothesize that Lactobacillus supplementation will change the pattern of intestinal colonization throughout the first year of life. Stool samples have been collected from both groups (at birth, 1, 3, 6, 9 and 12 months of age). We will assess neonatal gut bacterial community composition using a novel 16S rRNA PhyloChip microarray approach, which will assess Lactobacillus colonization, bacterial community structure (presence or absence of specific taxa as inferred from microarray fluorescence intensity), as well as bacterial community dynamics (longitudinal differences in bacterial community development). In this cohort, we have used monthly follow-up to assess potential confounding factors such as exposure to breastfeeding, antibiotics, daycare, siblings, pets and foreign travel. We have data on adherence based on pill counts and stool analyses. We will use multivariate regression methods to test for differences between the control and intervention groups in the extent of Lactobacillus colonization, total bacteria community structure and bacterial community temporal dynamic patterns. Based on the results of this secondary analysis, we will further understand how changes in gut bacterial community may affect the development of atopy. This data will give us an estimate of the overall magnitude and rate of changes in bacterial communities with Lactobacillus supplementation, as well as which of different measures of bacterial community composition are most associated with changes in early markers of asthma.
PUBLIC HEALTH RELEVANCE: We propose the Probiotic Outcomes on Enteric Microbiotia (POEM) Study, which is a pilot study to help us understand how probiotic supplementation of newborn babies affects the bacteria that colonize their gut, and how such changes in the bacterial population affect the likelihood of developing early markers of asthma. We will use a new cutting-edge technology, the PhyloChip, to identify bacteria from stool samples of the infants in the study. Data from the POEM pilot study will help us find ways of potentially preventing early signs of asthma through dietary supplementation of infants.
描述(由申请人提供):我们提出了肠道微生物(Poem)研究的益生菌结果,该研究是对婴儿补充益生菌的试验(TIPS)研究的先前收集样品的二次数据分析,以防止哮喘的标志(HL080074)。旨在研究每天补充乳杆菌对婴儿的影响6个月的影响对哮喘早期标记到三岁的早期标记的影响;使用278个婴儿的双盲,安慰剂对照研究设计。在拟议的诗歌研究中,我们将采用一种新颖的16S rRNA phylachip微阵列方法,该方法是一种与培养的,众多的平行方法,用于同时对细菌的半定量检测。在从尖端队列中收集的粪便样品样本(n = 60)的样品中,使用植物芯片微阵列为表征益生菌补充剂如何改变肠道细菌群落的机会提供了机会。这首诗试验研究的总体目标是应用一项最先进的技术来开发初步数据,以确定补充每日益生菌对胃肠道细菌群落的影响。我们将(1)评估补充乳杆菌对新生儿肠道细菌群落的延长作用和(2)在补充六个月的补充期间和之后,以及(3)将细菌群落组成对哮喘早期标记发展的影响。我们假设补充乳杆菌将改变整个生命的第一年。粪便样品均已从两组(出生时1、3、6、9和12个月大)收集。我们将使用一种新颖的16S rRNA phylochip微阵列方法来评估新生儿肠道细菌群落组成,该方法将评估乳酸杆菌定植,细菌群落结构(细菌群落结构(从微阵列荧光强度中推断出的特定分类),以及细菌群落动力学(细菌群体差异)(细菌群体差异)。在此队列中,我们使用每月的随访来评估潜在的混杂因素,例如暴露于母乳喂养,抗生素,日托,兄弟姐妹,宠物和外国旅行。我们获得了基于药丸计数和粪便分析的依从性数据。我们将使用多元回归方法在乳酸杆菌定植,总细菌群落结构和细菌群落时间动态模式的范围内测试对照组和干预组之间的差异。根据该二次分析的结果,我们将进一步了解肠道细菌群落的变化如何影响特应性的发展。这些数据将使我们对补充乳杆菌的细菌群落的总体变化和变化率进行估计,以及哪些不同量度的细菌群落组成量与早期哮喘的早期标志物的变化最相关。
公共卫生相关性:我们提出了肠性微生物(Poem)研究的益生菌结果,该研究是一项试点研究,旨在帮助我们了解益生菌补充新生婴儿如何影响肠道殖民的细菌,以及细菌种群中这种变化如何影响发展哮喘的早期标志物的可能性。我们将使用一种新的尖端技术phylochip来鉴定研究中婴儿粪便样品的细菌。诗歌试验研究的数据将帮助我们找到通过补充婴儿饮食来预防哮喘早期迹象的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael D Cabana其他文献
Michael D Cabana的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael D Cabana', 18)}}的其他基金
Probiotic Outcomes in Enteric Microflora (POEM) Study
肠道菌群 (POEM) 研究中的益生菌结果
- 批准号:
7938115 - 财政年份:2009
- 资助金额:
$ 37.45万 - 项目类别:
TRIAL OF INFANT PROBIOTIC SUPPLEMENTATION TO PREVENT ASTHMA
婴儿益生菌补充剂预防哮喘的试验
- 批准号:
7376595 - 财政年份:2006
- 资助金额:
$ 37.45万 - 项目类别:
Trial of Infant Probiotic Exposure on Developing Asthma
婴儿益生菌暴露对发生哮喘的试验
- 批准号:
7255480 - 财政年份:2004
- 资助金额:
$ 37.45万 - 项目类别:
Trial of Infant Probiotic Exposure on Developing Asthma
婴儿益生菌暴露对发生哮喘的试验
- 批准号:
7442291 - 财政年份:2004
- 资助金额:
$ 37.45万 - 项目类别:
Trial of Infant Probiotic Exposure on Developing Asthma
婴儿益生菌暴露对发生哮喘的试验
- 批准号:
7128025 - 财政年份:2004
- 资助金额:
$ 37.45万 - 项目类别:
Trial of Infant Probiotic Exposure on Developing Asthma
婴儿益生菌暴露对发生哮喘的试验
- 批准号:
7102572 - 财政年份:2004
- 资助金额:
$ 37.45万 - 项目类别:
Trial of Infant Probiotic Exposure on Developing Asthma
婴儿益生菌暴露对发生哮喘的试验
- 批准号:
6831001 - 财政年份:2004
- 资助金额:
$ 37.45万 - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Intensive postpartum antihypertensive treatment to improve women's cardiovascular health
产后强化抗高血压治疗可改善女性心血管健康
- 批准号:
10664483 - 财政年份:2023
- 资助金额:
$ 37.45万 - 项目类别:
Social Vulnerability, Sleep, and Early Hypertension Risk in Younger Adults
年轻人的社会脆弱性、睡眠和早期高血压风险
- 批准号:
10643145 - 财政年份:2023
- 资助金额:
$ 37.45万 - 项目类别:
Move and Snooze: Adding insomnia treatment to an exercise program to improve pain outcomes in older adults with knee osteoarthritis
活动和小睡:在锻炼计划中添加失眠治疗,以改善患有膝骨关节炎的老年人的疼痛结果
- 批准号:
10797056 - 财政年份:2023
- 资助金额:
$ 37.45万 - 项目类别:
Understand and mitigating the influence of extreme weather events on HIV outcomes: A global investigation
了解并减轻极端天气事件对艾滋病毒感染结果的影响:一项全球调查
- 批准号:
10762607 - 财政年份:2023
- 资助金额:
$ 37.45万 - 项目类别:
Probiotic Administration for Adolescent Depression
益生菌治疗青少年抑郁症
- 批准号:
10646130 - 财政年份:2023
- 资助金额:
$ 37.45万 - 项目类别: